Industry in brief | Acino, Dermapharm, Venture Life
30 March 2022
Acino has stepped up its presence in Saudi Arabia, Dermapharm has reported sales up by 19% and Venture Life has postponed its financial results announcement.
You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
30 March 2022
Acino has stepped up its presence in Saudi Arabia, Dermapharm has reported sales up by 19% and Venture Life has postponed its financial results announcement.
19 January 2022
Private-equity firm Ardian has taken a majority stake in Biofarma Group, Orkla has acquired Vesteralen Marine Olje, and Venture Life has appointed a new Chinese partner.
1 December 2021
Galenica is adding digital expertise to its Executive Committee, Venture Life has announced senior management changes, and Perrigo is set to get a new chairman.
25 August 2021
Dermapharm, Venture Life and Navamedic have released financial results.
11 August 2021
Self-care group Venture Life has acquired a trio of oncology support products, including Gelclair, from Switzerland’s Helsinn Healthcare in a deal worth CHF6.0 million (USD6.5 million).
7 June 2021
Self-care group Venture Life has acquired BBI Healthcare – including its Balance Activ brand for treating bacterial vaginosis – in a deal worth up to GBP36.0 million (USD50.9 million).
22 January 2021
Self-care group Venture Life is keen to acquire consumer healthcare brands following its recent funding round, according to chief executive officer Jerry Randall.